ConductScience.org, home

Gene · 2357

Papers4,418

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

181 to 200 of 4,418

Download this page as JSON
TitleJournalYearPMIDFound bySource
Immune mechanisms and signatures in lethal and non-lethal sepsis revealed by single-cell transcriptomics.J Immunol202540580488PubTator, text miningPubMed
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions.Nature202540562937PubTator, text miningPubMed
Precision leak detection in the golden window: emerging biomarker strategies for anastomotic integrity monitoring after low anterior resection.Int J Surg202540561163PubTator, text miningPubMed
Uncovering common disease mechanisms and critical biomarkers in Crohn's disease with concurrent psoriasis and exploring potential therapeutic agents.PLoS One202540540498PubTator, text miningPubMed
Potential targeting of urokinase-type plasminogen activator receptor-formyl peptide receptor signaling to prevent recurrence in posttransplant primary podocytopathies.Am J Transplant202540517817PubTator, text miningPubMed
Annexin A1-FPR1 Interaction in dendritic cells promotes immune microenvironment modulation in Thyroid Cancer.Cell Biol Toxicol202540483281PubTator, text miningPubMed
Kaminari: a resource-frugal index for approximate colored k-mer queries.bioRxiv202540475623PubTator, text miningPubMed
Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification.J Diabetes Investig202540470717PubTator, text miningPubMed
Artificial neural network risk prediction of COPD exacerbations using urine biomarkers.ERJ Open Res202540470144PubTator, text miningPubMed
Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2021-2024).Expert Opin Ther Pat202540462544PubTator, text miningPubMed
Author Correction: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils.Nat Commun202540447624PubTator, text miningPubMed
What is the potential of formyl peptide receptor 1 (FPR1) as a therapeutic target in human disease?Expert Opin Ther Targets202540437796PubTator, text miningPubMed
Exploring the therapeutic potential of annexin A1-derived peptide Ac2-26 in modulating NLRP3 inflammasome activation in Crohn's disease.Mol Cell Biochem202540397291PubTator, text miningPubMed
A novel neutrophil extracellular traps related diagnostic signature for intracranial aneurysm.BMC Neurol202540389926PubTator, text miningPubMed
GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization.Nat Commun202540374633PubTator, text miningPubMed
A KAN-based hybrid deep neural networks for accurate identification of transcription factor binding sites.PLoS One202540334196PubTator, text miningPubMed
Impact of a multi-component implementation strategy to increase outdoor free play opportunities in early childhood education and care (ECEC) services: the get outside get active (GOGA) randomised controlled trial.
Int J Behav Nutr Phys Act202540312713PubTator, text miningPubMed
Comparative analysis of automated foul detection in football using deep learning architectures.Sci Rep202540274843PubTator, text miningPubMed
An enhanced ensemble defense framework for boosting adversarial robustness of intrusion detection systems.Sci Rep202540268978PubTator, text miningPubMed
New Diterpenoids With Anti-Inflammatory Activity From Callicarpa rubella Collected in Vietnam.Phytochem Anal202540254804PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2357/papers?page=10